Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid
- 15 April 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (8), 2216-2219
- https://doi.org/10.1016/j.bmcl.2007.01.117
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- VorinostatNature Reviews Drug Discovery, 2007
- Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?Leukemia, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Synthesis and cancer antiproliferative activity of new histone deacetylase inhibitors: hydrophilic hydroxamates and 2-aminobenzamide-containing derivativesEuropean Journal of Medicinal Chemistry, 2006
- Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylasesBioorganic & Medicinal Chemistry, 2006
- Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or LymphomaJournal of Clinical Oncology, 2005
- Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone DeacetylasesStructure, 2004
- Thiol-based SAHA analogues as potent histone deacetylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- The synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductaseJournal of Medicinal Chemistry, 1989